Personal profile
Research interests
Cytokine Signaling, Gene Expression, Immune Defense, Cancer
Immune defense, differentiation, programmed cell death, and malignancy are all influenced by extracellular cytokines. Our research centers on the action of a subset of cytokines that stimulate Janus tyrosine kinases (JAKs) and signal transducers and activators of transcription (STATs). Activated JAK-STAT pathways rapidly transduce signals from outside the cell into the nucleus to regulate gene expression. Although the JAK-STAT cytokines use similar signal transduction pathways, their biological effects are quite diverse. For example, interferons confer resistance to viral infections, whereas interleukin-6 promotes inflammation and malignancy. We are currently exploring mouse models of viral infection and pancreatic cancer to identify molecular mechanisms that can be used to combat these diseases.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Center for Healthy Aging Pilot Program
Igarashi, P. (PI), DeLorenzo, C. (CoPI), Fields, S. (CoPI), Acosta Martinez, M. (CoI), Colognato, H. (CoI), Enikolopov, G. (CoI), Heslin, S. (CoI), Hu, C.-K. (CoI), Kaczocha, M. (CoI), Kim, H. (CoI), Kim, M. J. (CoI), Kumar, P. (CoI), Mackow, E. (CoI), Mathew, J. (CoI), Nadkarni, N. (CoI), Parker, M. (CoI), Rajupet, S. (CoI), Marshall, N. (CoI), Riessland, M. (CoI), Rozensky, R. (CoI), Sher, R. (CoI), Sheridan, B. (CoI), Singer, A. (CoI), Sunar, U. (CoI), Tsirka, S.-A. (CoI), Vorkas, C. (CoI), Wang, J. (CoI), Xiong, Q. (CoI) & Ye, F. (CoI)
08/1/23 → 12/31/27
Project: Research
-
COVID 19 Research Awards from SOM
Kim, H. (CoI), Mackow, E. (CoI), Palekar, N. (CoI), Parsey, R. (CoI), Marshall, N. (CoI), Sheridan, B. (CoI), Thanassi, D. (CoI) & Riley, J. (PI)
12/1/20 → 08/31/22
Project: Research
-
COVID-19 Non-Clinical Research: COVID-19 Antiviral and Therapeutic Approaches
Marshall, N. (PI), Hearing, P. (CoPI), Kim, H. (CoPI), Mackow, E. (CoPI) & Hearing, J. (CoPI)
06/1/20 → 11/30/22
Project: Research
-
STAT3 is a Critical Regulator of Tumor Cell Plasticity
Marshall, N. (PI), Powers, R. (CoI) & Sheridan, B. (CoI)
07/1/19 → 06/30/25
Project: Research
-
Defining ANDV Virulence and Attenuation Mechanisms
Mackow, E. (PI) & Marshall, N. (CoPI)
National Institute of Allergy & Infectious Disease
11/25/16 → 10/31/23
Project: Research
-
Intratumor heterogeneity in KRAS signaling shapes treatment resistance
Petrenko, O., Kirillov, V., D'Amico, S. & Reich, N. C., Feb 21 2025, In: iScience. 28, 2, 111662.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
STAT3 sustains tumorigenicity following mutant KRAS ablation
D’Amico, S., Kirillov, V., Liu, J., Qiu, Z., Lei, X., Qin, H., Sheridan, B. S. & Reich, N. C., Oct 23 2025, In: EMBO Reports. 26, 20, p. 4900-4922 23 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Multifaceted roles for STAT3 in gammaherpesvirus latency revealed through in vivo B cell knockout models
Hogan, C. H., Owens, S. M., Reynoso, G. V., Liao, Y., Meyer, T. J., Zelazowska, M. A., Liu, B., Li, X., Grosskopf, A. K., Khairallah, C., Kirillov, V., Reich, N. C., Sheridan, B. S., McBride, K. M., Gewurz, B. E., Hickman, H. D., Craig Forrest, J. & Krug, L. T., Feb 2024, In: mBio. 15, 2Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Oncogenic dependency plays a dominant role in the immune response to cancer
Li, J., Amico, S. D., Kirillov, V., Petrenko, O. & Reich, N. C., Oct 3 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 41, e2308635120.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Howard Young Commentary
Marshall, N. C. R., Dec 1 2022, In: Journal of Interferon and Cytokine Research. 42, 12, p. 603 1 p.Research output: Contribution to journal › Comment/debate